Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Insulin Detemir | |
| Synonyms |
|
|
| Definitions |
A long-lasting, recombinant version of human insulin. It is an insulin analogue with myristic acid bound to the lysine at position B29 and a deletion of B30. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C65920 |
|
| CAS_Registry |
169148-63-4
|
|
| Chemical_Formula |
C267H402N64O76S6
|
|
| code |
C65920
|
|
| Contributing_Source |
FDA
|
|
| definition |
A long-lasting, recombinant version of human insulin. It is an insulin analogue with myristic acid bound to the lysine at position B29 and a deletion of B30.
|
|
| FDA_UNII_Code |
4FT78T86XV
|
|
| in_subset | ||
| label |
Insulin Detemir
|
|
| Legacy Concept Name |
Insulin_Detemir
|
|
| Preferred_Name |
Insulin Detemir
|
|
| prefixIRI |
NCIT:C65920
|
|
| prefLabel |
Insulin Detemir
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C0537270
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping